KFG Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.65M Buy
1,378
+870
+171% +$889K 0.19% 64
2026
Q1
$467K Buy
508
+30
+6% +$30.4K 0.06% 142
2025
Q4
$514K Buy
478
+5
+1% +$4.78K 0.07% 132
2025
Q3
$361K Buy
473
+16
+4% +$11.9K 0.05% 152
2025
Q2
$356K Buy
457
+31
+7% +$24.1K 0.06% 147
2025
Q1
$352K Sell
426
-27
-6% -$22.5K 0.06% 143
2024
Q4
$350K Sell
453
-93
-17% -$77K 0.07% 130
2024
Q3
$484K Sell
546
-12
-2% -$10.8K 0.11% 117
2024
Q2
$505K Buy
558
+50
+10% +$40K 0.2% 90
2024
Q1
$395K Buy
508
+16
+3% +$11.4K 0.16% 104
2023
Q4
$287K Sell
492
-100
-17% -$58.4K 0.13% 102
2023
Q3
$318K Hold
592
0.17% 98
2023
Q2
$277K Hold
592
0.16% 96
2023
Q1
$222K Sell
592
-18
-3% -$6.07K 0.15% 86
2022
Q4
$223K Buy
+610
New +$216K 0.23% 66

Other funds holding LLY

KFG Wealth Management's LLY Position: Q2 2026 in Review

KFG Wealth Management increased its Eli Lilly (LLY) stake by 171% in Q2 2026, buying an estimated $889K and bringing the position to 1,378 shares worth $1.65M. The position accounts for 0.19% of the portfolio, ranked #64.

KFG Wealth Management first reported a position in LLY in Q4 2022 and has held it in 15 quarters since. 1,608 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • KFG Wealth Management held 1,378 shares of Eli Lilly worth $1.65M as of Q2 2026.
  • KFG Wealth Management bought 870 Eli Lilly shares in Q2 2026, an estimated $889K.
  • Eli Lilly made up 0.19% of KFG Wealth Management's portfolio in Q2 2026, its #64 holding.
  • KFG Wealth Management first reported a position in Eli Lilly in Q4 2022 and has held it in 15 quarters since.
  • 1,608 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on KFG Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.